1st Edition

The Changing Face of Japanese Management

By Keith Jackson, Miyuki Tomioka Copyright 2004
    272 Pages
    by Routledge

    274 Pages
    by Routledge

    For many western managers the approach taken by successful Japanese organisations and their managers has tended to inspire awe, envy and incomprehension in equal measure. But what is so special about 'Japanese' management? And how 'special' is the response of Japanese managers to global business pressures ?

    This textbook addresses these questions. It presents case examples generated from interviews with Japanese managers in Japan, Europe and the USA, contextualising their comments by reference to recent research in the fields of international and intercultural management. The book explains how and why individual managers variously perceive threats or opportunities in the business and career environments currently evolving both inside and outside Japan. It combines vivid images of the expected and the exceptional, the traditional with the new and unfamiliar.
    The Changing Face of Japanese Management offers management students with little prior knowledge of Japanese business and society, critical insights into what is happening inside Japanese management today. It also offers clear and immediately transferable insights to management practitioners who are preparing to work or negotiate with Japanese business partners.

    1. First Encounters 2. The Face of Japanese Management 3. Learning to Work 4. Starting a Career 5. Losing Patience 6. Losing Trust? 7. Regaining Confidence 8. Facing the Future


    Keith Jackson is a tutor and researcher at the Centre for Financial & Management Studies (CeFiMS) at The School of Oriental and African Studies, University of London. He is currently involved in developing an on-line MBA community based in Konstanz (Germany)

    Miyuki Tomioka is currently working for an international management and business consultancy in Japan. She specialises in strategy, e-commerce, and mergers and acquisitions in the global pharmaceuticals and biotechnology industries.